Creatv Microtech Funding: How Much Did They Raise & Key Investors

How Much Did Creatv Microtech Raise?
Funding & Key Investors

Creatv Microtech has solidified its position in the advanced diagnostics sector, securing a total capital infusion of $150K. This latest financial milestone, characterized by a $150K major strategic investment, underscores the market confidence in the firm's proprietary microfabrication capabilities. As the company transitions through its late-stage growth phase, this influx of resources serves to accelerate the commercial deployment of its high-precision diagnostic platforms.

The trajectory of Creatv Microtech reflects a sustained commitment to engineering excellence, moving from foundational research to the large-scale implementation of its core technologies. By securing this significant backing, the organization is well-positioned to scale its operations and address the growing demand for non-invasive cancer screening solutions in a competitive global landscape.

What is Creatv Microtech?

Creatv Microtech

Business Services

Research & Development

Healthcare Services

Founded by Dr. Cha-Mei Tang, Creatv Microtech operates at the intersection of high-aspect-ratio microfabrication and ultra-sensitive biodetection. The company is best known for its CellSieve technology, a sophisticated microfilter system designed to facilitate liquid cell biopsies. This innovation allows for the isolation and analysis of circulating tumor cells with unprecedented accuracy, providing clinicians with critical data for cancer diagnostics and personalized treatment planning. By leveraging unmatched expertise in micro-metal and composite microstructures, Creatv Microtech maintains a distinct competitive advantage in the medical technology sector, effectively bridging the gap between complex engineering and clinical utility.

How much funding has Creatv Microtech raised?

Creatv Microtech has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Creatv Microtech

PPP

Public-Private Partnership

What's next for Creatv Microtech?

With the recent injection of capital, Creatv Microtech is poised to expand its footprint in the oncology diagnostics market. The strategic focus will likely center on scaling the manufacturing of its CellSieve microfilters to meet international clinical demand and enhancing its R&D pipeline for next-generation biodetection tools. As the company matures, the emphasis will shift toward broader regulatory approvals and the integration of its diagnostic platforms into standard clinical workflows. This late-stage financing provides the necessary runway to solidify its market leadership, potentially paving the way for strategic partnerships or further commercial expansion in the rapidly evolving field of liquid biopsy.

See full Creatv Microtech company page

See More Financial Insights